WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 2-Jul-2015 (Data received as of 26-June-2015)
Next overall update Mid July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 4101 Infant (under 12 months) mortality rate: 562
GDP / capita (US$): 8781 Child (under 5 years) mortality rate: 752

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 4'397  4'294  4'190  4'080  3'958  2'892  2'103  1'893 
Births 154  152  150  148  146  119  95  93 
Surviving infants 145  143  141  139  136  105  80  79 
Pop. less than 5 years 693  686  678  668  655  496  371  348 
Pop. less than 15 years 1'874  1'842  1'806  1'764  1'716  1'250  948  850 
Female 15-49 years 1'030  1'002  976  948  919  676  473  428 

Number of reported case

(Click for retrospective incidence data for Liberia)
Diphtheria
Japanese encephalitis
Measles 34  43  279  2'200  5'977  6'567 
Mumps
Pertussis 281  62 
Polio* 98 
Rubella 39 
Rubella (CRS)
Tetanus (neonatal) 12  152  207 
Tetanus (total)** 12  228  307 
Yellow fever 17  137 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Liberia)
Vaccine year result method % card seen                                                
BCG 2012  94  DHS   58  73  87  85  85  76  45 
DTP1 2012  91  DHS   58  74  97  99*  86  85 
DTP3 2012  71  DHS   58  63  89  93  77  75  48 
HepB_BD         
HepB3 2012  71  DHS   58  63  89  93  77  75 
Hib3 2012  71  DHS   58  63  89  93  77  75 
JapEnc         
MCV          58  74  80  71  72  52 
MCV2         
PCV1          90 
PCV3          45 
Pol3 2012  70  DHS   58  62  88  93  77  60  52 
Rota1         
Rota_last         
Rubella1         
TT2plus 1994  77  MICS     68  76  74  74  63  25 
PAB         
VAD1          25  58  43  56  63  26 
YFV 2012  73  DHS   58  54  73  78  70  71 
  ° indicates that more than 1 survey occurred that year

  Next update: Mid July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Liberia)
BCG 87  85  85  73  78 
DTP1 97  97  86  80  80 
DTP3 89  93  77  70  46 
HepB3 89  93  77  47 
HepB_BD
Hib3 89  93  77  47 
MCV 74  80  71  65  63 
MCV2
PAB 91  91  91  91  51  33 
PCV3
Pol3 88  93  77  71  56 
Rota_last
YFV 73  78  70  64 

Number of districts in the country 15  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 13
From 50 to 79% 73
Less than 50% 13
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HPV 9-13 years (2 doses); No From October 2015
IPV 14 weeks; Yes From October 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; Yes From January 2016
TT 14 years; +1, +6 months; +1, +1 year; Yes and pregnant women
VitaminA 6 months; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2011-2015  2011-2015  2011-2015  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 15  15  15  15  15  15 

System performance

Total Nº districts in country number 15  15  15  15  15  15  15 
Nº districts with DTP3 coverage >=80% number 13  14  13  14 
% of districts with DTP3 coverage >=80% From 0 to 100% 13  87  93  53  47  87  93 
Nº districts with measles (MCV1) coverage >=95% number 10  12 
% of districts with MCV1 coverage >=95% From 0 to 100% 13  13  67  80 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  No    Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 28         

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  No  No  No  No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.